References
Breddin HK. Reviparin sodium-a new low molecular weight heparin. Expert Opin Pharmacother. 2002;3:173–182.
Shapiro SS, Hultin M. Acquired inhibitors to the blood coagulation factors. Semin Thromb Hemost. 1975;1:336–385.
Saud MA. Laboratory diagnosis of inhibitors. Semin Thromb Hemost. 2000;26:195–203.
Feinstein DI. Immune coagulation disorders. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:1003–1020.
Lalwani RB, Stricker RB. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency. Am J Med Sci. 1992;303:398–401.
Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol. 2002;68:307–309.
Schwartz RS, Begriel DA, Aledort LM, et al. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high dose intravenous immunoglobulin. Blood. 1995;86:797–804..
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
De Giorgi, A., Giannarelli, C., De Negri, F. et al. Thromboprophylaxis with Reviparin in a Patient with Acquired Hemophilia. Int J Hematol 81, 176–177 (2005). https://doi.org/10.1532/IJH97.E0408
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.E0408